Clinical Trials Browser

Interventional × Digestive System Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT06022692 2023-09-05

HEAIS001

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

NCT05913661 2023-06-22

Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Digestive System Neoplasms, Cholangiocarcinoma